Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)
1.120
+0.040
(+3.70%)
Streaming Delayed Price
Updated: 3:20 PM EDT, Jul 21, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 371,349 |
| Open | 1.080 |
| Bid (Size) | 1.120 (700) |
| Ask (Size) | 1.130 (1,000) |
| Prev. Close | 1.080 |
| Today's Range | 1.080 - 1.135 |
| 52wk Range | 0.8127 - 4.190 |
| Shares Outstanding | 5,726,750 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
February 23, 2026
Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company
February 23, 2026
Frequently Asked Questions
Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.120
When was Phio Pharmaceuticals Corp. - Common Stock last traded?
The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 07/21/26 03:20 PM ET
What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 6.41M
How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
Phio Pharmaceuticals Corp. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.